The promise of practical innovation

Not all innovation comes in the form of sweeping change. Instead, it can be about taking another step forward on a proven path. Or about looking at what works well and finding ways to make it work better. It’s what we call practical innovation.

At New American Therapeutics, Inc. the inherent promise of practical innovation within the biopharmaceutical industry grounds all we do. Our initial focus isn’t on early research or the most cutting edge chemistries, the newest categories or the next blockbuster. It’s on taking proven therapies and supporting incremental changes that can make meaningful differences in the lives of patients, the work of healthcare providers and the success of our partners.

There is great promise in practical innovation. And at New American Therapeutics, we’re living it every single day.

In The News

The reintroduction of
Denavir^® (penciclovir cream, 1%) symbolizes the power of applying practical innovation to existing brands for the benefit of patients and our partners. And, it also represents our commitment to placing a new commercial emphasis on an established brand.

Read the press release

Commercialization Platform

Whether you have an in-line, launch or emerging biopharmaceutical product, taking the fastest and surest way to market is non-negotiable when it comes to success. With New American Therapeutics, you’ll share the journey with those who have taken many products along this path effectively and profitably time and time again.